Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages
Stefano Ugel, Francesco De Sanctis, Susanna Mandruzzato, et al.
Journal of Clinical Investigation (2015) Vol. 125, Iss. 9, pp. 3365-3376
Open Access | Times Cited: 495

Showing 1-25 of 495 citing articles:

Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Vincenzo Bronte, Sven Brandau, Shu‐Hsia Chen, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 2371
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Vinit Kumar, Sima Patel, Evgenii N. Tcyganov, et al.
Trends in Immunology (2016) Vol. 37, Iss. 3, pp. 208-220
Open Access | Times Cited: 1741
Cancer immunoediting and resistance to T cell-based immunotherapy
Jake S. O’Donnell, Michele W.L. Teng, Mark J. Smyth
Nature Reviews Clinical Oncology (2018) Vol. 16, Iss. 3, pp. 151-167
Closed Access | Times Cited: 1423
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives
Xiaoqi Mao, Jin Xu, Wei Wang, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 1390
Cancer immunotherapy: harnessing the immune system to battle cancer
Yiping Yang
Journal of Clinical Investigation (2015) Vol. 125, Iss. 9, pp. 3335-3337
Open Access | Times Cited: 1207
IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance
David H. Munn, Andrew L. Mellor
Trends in Immunology (2016) Vol. 37, Iss. 3, pp. 193-207
Open Access | Times Cited: 860
Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells
Olivier De Henau, Matthew Rausch, David A. Winkler, et al.
Nature (2016) Vol. 539, Iss. 7629, pp. 443-447
Open Access | Times Cited: 748
Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer
Kai Li, Houhui Shi, Benxia Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 511
Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade
Dipongkor Saha, Robert L. Martuza, Samuel D. Rabkin
Cancer Cell (2017) Vol. 32, Iss. 2, pp. 253-267.e5
Open Access | Times Cited: 500
EMT and inflammation: inseparable actors of cancer progression
Meggy Suarez‐Carmona, Julien Lesage, Didier Cataldo, et al.
Molecular Oncology (2017) Vol. 11, Iss. 7, pp. 805-823
Open Access | Times Cited: 487
Immune suppressive mechanisms in the tumor microenvironment
David H. Munn, Vincenzo Bronte
Current Opinion in Immunology (2015) Vol. 39, pp. 1-6
Open Access | Times Cited: 452
CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma
Andras Heczey, Chrystal U. Louis, Barbara Savoldo, et al.
Molecular Therapy (2017) Vol. 25, Iss. 9, pp. 2214-2224
Open Access | Times Cited: 450
Targeting the microenvironment in solid tumors
Carmen Belli, Dario Trapani, Giulia Viale, et al.
Cancer Treatment Reviews (2018) Vol. 65, pp. 22-32
Closed Access | Times Cited: 430
Combination strategies to maximize the benefits of cancer immunotherapy
Shaoming Zhu, Tian Zhang, Lei Zheng, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 426
Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression
Viktor Fleming, Xiaoying Hu, Rebekka Weber, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 400
HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer
T. Barnes, Eitan Amir
British Journal of Cancer (2017) Vol. 117, Iss. 4, pp. 451-460
Open Access | Times Cited: 386
Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities
Vinod P. Balachandran, Gregory L. Beatty, Stephanie K. Dougan
Gastroenterology (2019) Vol. 156, Iss. 7, pp. 2056-2072
Open Access | Times Cited: 382
Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)
Patrick Danaher, Sarah Warren, Rongze Lu, et al.
Journal for ImmunoTherapy of Cancer (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 361
Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy
Adriana Albini, Antonino Bruno, Douglas M. Noonan, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 348
High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade
Kobe Yuen, Lifen Liu, Vinita Gupta, et al.
Nature Medicine (2020) Vol. 26, Iss. 5, pp. 693-698
Open Access | Times Cited: 347
Tumor-Associated Macrophages: Implications in Cancer Immunotherapy
Amy J. Petty, Yiping Yang
Immunotherapy (2017) Vol. 9, Iss. 3, pp. 289-302
Open Access | Times Cited: 319
Tumor promoting role of anti-tumor macrophages in tumor microenvironment
Kuntal Kanti Goswami, Tithi Ghosh, Sarbari Ghosh, et al.
Cellular Immunology (2017) Vol. 316, pp. 1-10
Closed Access | Times Cited: 293
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells
Giada Mondanelli, Roberta Bianchi, Maria Teresa Pallotta, et al.
Immunity (2017) Vol. 46, Iss. 2, pp. 233-244
Open Access | Times Cited: 291
Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy
Matthias Pinter, Rakesh K. Jain
Science Translational Medicine (2017) Vol. 9, Iss. 410
Open Access | Times Cited: 275
Migrating into the Tumor: a Roadmap for T Cells
Lieke L. van der Woude, Mark A.J. Gorris, Altuna Halilović, et al.
Trends in cancer (2017) Vol. 3, Iss. 11, pp. 797-808
Open Access | Times Cited: 268
Page 1 - Next Page

Scroll to top